ATLASVera Therapeutics (VERA) earnings date: Nov 5, 2026
Vera Therapeutics (VERA) reports earnings for the quarter ended Sep 30, 2026 on Thu, Nov 5, 2026, after the close. Analysts expect EPS of -$1.72.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on VERA
| Last price | $31.30 (+1.0%) |
|---|---|
| Normal 1-day range (±1σ) | ±3.7% |
| Earnings beat history | Beat the EPS estimate in 1 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Vera Therapeutics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Vera Therapeutics reports on Nov 5, 2026. One email the day before, with ATLAS’s read on Vera Therapeutics. You can switch it off at any time.
Alert me before VERA reportsFree to start. Creating an account takes under a minute.
Notify me when Vera Therapeutics reports
Track VERA free Add Vera Therapeutics to a free ATLAS watchlist and see its next report date in one place.
VERA earnings at a glance
| Next report (confirmed) | Thu, Nov 5, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$1.72 |
| Last report | Aug 10, 2026 · Beat |
| Beat rate (last 5 reports) | 1 of 5 (20%) |
| Average EPS surprise | -17.4% |
| Average move around a report | ±3.2% (last 5) |
| Sector | Healthcare · Biotechnology |
Vera Therapeutics earnings history: last 5 reports
Vera Therapeutics last reported on Aug 10, 2026: EPS of -$1.52 against an estimate of -$1.59 (+4.4% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 10, 2026 | -$1.59 | -$1.52 | +4.4% | Beat | -7.9% |
| Jul 31, 2026 | $0.49 | $0.36 | -26.5% | Miss | -2.5% |
| May 7, 2026 | -$1.37 | -$1.69 | -23.4% | Miss | -1.1% |
| Mar 11, 2026 | -$1.30 | -$1.72 | -32.3% | Miss | +2.3% |
| Feb 26, 2026 | -$1.27 | -$1.39 | -9.4% | Miss | -2.1% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for VERA
See the fair value, the probability range and the earnings history of Vera Therapeutics on its ATLAS page.
Vera Therapeutics (VERA) stock analysisPlans from €3.99 a month.
Vera Therapeutics earnings: frequently asked questions
When does Vera Therapeutics (VERA) report earnings?
Vera Therapeutics is scheduled to report on Thursday, November 5, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for VERA?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$1.72 per share (USD). Estimates can change before the report.
How often does VERA beat earnings estimates?
Of its last 5 reports with a recorded result, Vera Therapeutics beat the EPS estimate 1 times; the average surprise was -17.4%. Past results do not predict the next one.
How much does VERA move around earnings?
Over its last 5 reports the stock moved an average of 3.2% (absolute, from the close before the report day to the close after it), and finished higher 1 of 5 times.
Did Vera Therapeutics beat earnings estimates last quarter?
Vera Therapeutics last reported on Aug 10, 2026: EPS of -$1.52 against an estimate of -$1.59 (+4.4% surprise), a beat.
How much does VERA usually move in a day?
On a normal trading day the ATLAS model puts VERA’s one-day range at about ±3.7%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Nov 5, 2026
Educational information, not investment advice. Disclaimer